GM-CSF treatment enables mice transgenic for CD4-specific expression of human CD4, CCR5 and CyclinT1 to support in vitro and in vivo HIV infection

MLA

Seay, K., et al. “GM-CSF Treatment Enables Mice Transgenic for CD4-Specific Expression of Human CD4, CCR5 and CyclinT1 to Support in Vitro and in Vivo HIV Infection.” Journal of Reproductive Immunology, vol. 94, no. 1, May 2012, pp. 128–29. EBSCOhost, https://doi.org/10.1016/j.jri.2012.03.484.

APA

Seay, K., Qi, X., Zheng, J. H., Dutta, M., Ochsenbauer, C., Kappes, J. C., Santambrogio, L., Littman, D. R., & Goldstein, H. (2012). GM-CSF treatment enables mice transgenic for CD4-specific expression of human CD4, CCR5 and CyclinT1 to support in vitro and in vivo HIV infection. Journal of Reproductive Immunology, 94(1), 128–129. https://doi.org/10.1016/j.jri.2012.03.484

Chicago

Seay, K., X. Qi, J.H. Zheng, M. Dutta, C. Ochsenbauer, J.C. Kappes, L. Santambrogio, D.R. Littman, and H. Goldstein. 2012. “GM-CSF Treatment Enables Mice Transgenic for CD4-Specific Expression of Human CD4, CCR5 and CyclinT1 to Support in Vitro and in Vivo HIV Infection.” Journal of Reproductive Immunology 94 (1): 128–29. doi:10.1016/j.jri.2012.03.484.